Skip to content
Pharma Observatory a Scientist.com platform

Condition (MeSH)

Rocky Mountain Spotted Fever

ClinicalTrials.gov lists 1 trial for Rocky Mountain Spotted Fever or a narrower condition beneath it.

MeSH D012373 Infections C01 Listed by Orphanet as a rare disease
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Trials started per year Trials started per year 1 Trials by phase Trials by phase 1 Trials by recruitment status Trials by recruitment status 1 Publications Publications 1 Prevalence Prevalence 6 Rare-disease identity Rare-disease identity 2 Trials started per year Trials started per year 1 Trials by phase Trials by phase 1 Trials by recruitment status Trials by recruitment status 1 Publications Publications 1 Prevalence Prevalence 6 Rare-disease identity Rare-disease identity 2

Rows recorded per section

3 sections measured, none recorded · 1 not measured yet · 1 not computed

1 of the 1 trial is tagged with Rocky Mountain Spotted Fever itself; the rest are tagged with a narrower condition beneath it.

Get the Rocky Mountain Spotted Fever report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

When did Rocky Mountain Spotted Fever trials start? (1)

Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Trials started per year
Year Trials started
2022 1

No forecast is made for this condition: it averages 0.2 trial starts a year over the five years to September, under the 5 a year the method needs.

Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

What phase are Rocky Mountain Spotted Fever trials in? (1)

Shown in this order: phase order.

Trials by phase
Phase Trials
Phase 3 1

How many Rocky Mountain Spotted Fever trials are recruiting? (1)

Shown in this order: the order a trial moves through, from not yet recruiting to unknown.

Trials by recruitment status
Status Trials
Unknown status 1

Status as registered on ClinicalTrials.gov. Each trial is counted once.

Which publications cover Rocky Mountain Spotted Fever? (1)

Shown in this order: major-topic papers first, then newest, then most linked to trials.

Publications
Publication Journal Year Major topic
Questions on Mediterranean spotted fever a century after its discovery. Emerging infectious diseases 2008 No

Prevalence (6)

Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.

Prevalence
Orphanet disease Type Class Geography Jurisdiction Mapping relation
Rocky Mountain spotted fever Annual incidence 1-9 / 1 000 000 United States US Unspecified
Rocky Mountain spotted fever Annual incidence 1-9 / 1 000 000 United States US Exact
Rocky Mountain spotted fever Annual incidence 1-9 / 1 000 000 United States US Exact
Rocky Mountain spotted fever Point prevalence Unknown Worldwide Not stated Exact
Rocky Mountain spotted fever Point prevalence Unknown Worldwide Not stated Exact

Rare-disease identity (2)

Shown in this order: exact, broader, narrower, other.

Rare-disease identity
Orphanet disease ORPHA code Relation Source
Rocky Mountain spotted fever 83311 Exact Orphadata Science knowledge files, Product 1
Rocky Mountain spotted fever 83311 Exact Orphanet Rare Disease Ontology (ORDO)

Not on this page

Not measured: delivery record.

Checked, with nothing recorded for this condition: lead sponsors, serious adverse events in this condition's trials, and sub-conditions in mesh.

Not computed for conditions with fewer than 10 trials: drugs tested.

Browse all condition evidence pages